Key Takeaways
- Volume up, value down: Volume grew ~2.6% QoQ but revenue fell ~2.8% because declining vegetable oil prices dragged down finished product selling prices, a dynamic outside management's control.
- Margin recovery underway: EBITDA margin improved ~230 bps QoQ to 13.37%, driven by more efficient material consumption, with management targeting a return to 15%+ levels last seen during COVID.
- Isostearic acid: the margin catalyst is now live: The inaugural export shipment sailed in December 2023, assets were capitalized, and full capacity utilization is targeted by December 2024. Management calls it a high-value product that will "add substantially to the bottom line."
- A second new product is in the pipeline: Work has restarted on a product no one makes in India, using a different raw material within the core vegetable oils competency. It is a tricky product with a much higher average sales value, but no timeline is committed.
- What to watch next quarter: Isostearic acid revenue recognition from the first shipment, the pace of customer approvals in Europe, and any update on the new product's development timeline.
Isostearic Acid: The New Margin Engine
- First-mover advantage: Fairchem is the only manufacturer in India and one of only 5–6 globally, all in developed countries. The product took 5–6 years of in-house development from lab to pilot to plant scale because no technology is available for license.
- Revenue recognition imminent: The first export shipment to a large European customer sailed in late December 2023 on CIF terms; revenue will be recognized in Q4 FY24 once the vessel reaches port.
- Full capacity by year-end: Management expects to achieve full capacity production and sale of the 2,000 metric ton annual capacity by December 2024, based on positive response from overseas users over the last 3–4 months.
- Margin profile guarded but bullish: Management repeatedly declined to quantify Isostearic acid's margin or realization, citing UPSI concerns, but stated it will "add substantially to the bottom line" and help the company reach or surpass 15%+ EBITDA margins.
- Insulation from China: Isostearic acid faces no competition from China or India, directly insulating Fairchem from the Chinese dumping risk that affects its dimer acid business.
- FY25 growth hinge: Management stated that if the first commercial shipment had occurred in Q4 FY24, the company would have reached or surpassed FY23 sales and nearly matched FY23 bottom line; for FY25, it hopes to achieve both top-line and bottom-line growth.
Nahoosh Jariwala: "We are one of the only I mean in fact we are the only manufacturer in India and one of the few in the world. There are hardly 5 or 6 players and the product what we have made needs the international specification."
Volume vs Value: The Structural Divergence
- The mechanism: Finished product selling prices are linked to refined soya oil prices. When oil prices fall, revenue falls even as volumes rise. Volume grew 2.6% QoQ while value declined ~2.8% for exactly this reason.
- Volatility is the enemy, not price level: If oil prices move up, both raw material and finished product prices rise in tandem; if they fall, both fall. The problem is sharp swings, not absolute levels. Management sees volatility settling into a FY21-22 pattern, a narrower band than the post-Russia-Ukraine extremes.
- 12–15% volume growth achievable: Management expects year-end volume growth of 12–15%, but value growth may not match because it depends on refined soya oil price movement over the full year.
- Pricing benchmark clarification: Dimer and linoleic acid pricing tracks soft oil byproducts, not palm oil or the fatty acid WPI index.
Rajen Jhaveri: "We have a control or we can look for higher volume, but as far as absolute value is concerned it is not 100% in our hands."
Product Mix & Competitive Position
| Product | Competitive Position | Demand Signal |
|---|---|---|
| Linoleic acid (paint segment) | Only company in India making that grade; others make inferior product. China cannot compete due to freight component. | Normal demand, no drop and no surge; new paint entrants are coming in and Fairchem is working closely with them. Grasim's plant approved for supply, expected on stream next quarter. |
| Dimer acid | Competition only from China. Dumping occurred in Q1 FY24 but for the last 4–6 months shipments have been normal with no substantially reduced prices. | ~24–25% of product mix, likely to hold near-term until Isostearic acid ramps. |
| Isostearic acid | First in India, perhaps in Asia; no competition from India or China. Only 5–6 global players. | First export shipment done; full capacity (2,000 MT) targeted by December 2024. |
| New product (unnamed) | No one makes in India; few manufacturers globally. Uses a different raw material within vegetable oils/fatty acids core competency. | Development restarted on fast-track; tricky product, timeline uncertain. |
- Mix stability near-term: Until Isostearic acid goes "full blast," paint segment (~49–50%) and dimer acid (~24–25%) shares are likely to hold, with some quarterly plus/minus between the two.
- Customer retention intact: The company maintained its customer base without losing any big or small customers.
Capacity & Expansion Optionality
- 80,000-ton utilization target: Management is optimistic about reaching 90% utilization of the 80,000-ton capacity in the next year.
- 40,000-ton flexibility: The 40,000 tons earmarked for new products can be reduced to 20,000 tons, freeing 20,000 tons for current products if demand outstrips supply.
- Isostearic acid sits within existing capacity: The 2,000-ton Isostearic acid capacity is part of the 80,000-ton earmark, not the 40,000-ton new product earmark. It uses existing fatty acid assets plus some assets originally created for the new project. No separate capex was required.
- Brownfield expansion possible: If the new project succeeds and regular product utilization rises, the company can expand. It has substantial cash flow, no debt, and an adjoining piece of land available.
- Solar power derisking: Gujarat's new policy now allows 100% of power requirement from solar (previously 50%). The company has started searching for suitable land; everything else is set.
- Nutraceutical project on hold: Deemed not viable; the land bought for it has already been repurposed for the 1,20,000-ton expansion, Isostearic acid, and the new product. No excess land remains at the current location.
Rajen Jhaveri: "Over a period of last 27 years that we are in this business what we have understood is rather than putting so much of pressure on the availability of raw material and selling finished goods by trying to attempt more and more quantity it is always better to diversify and take this new set of product which no one in India makes."
External Risks & Mitigants
- Red Sea crisis: Shipments rerouted around Africa, adding 15–20 days transit time and higher freight costs. The product is high-value so the percentage impact on sales is miniscule; business is not materially impacted. If the situation persists when Isostearic acid goes "full blast," transit time and freight will be somewhat higher.
- China dumping contained: Dumping from China affected dimer acid only in Q1 FY24; the last 4–6 months have seen normal shipments. China does not make Isostearic acid, and cannot compete in the paint segment due to freight costs. Isostearic acid directly insulates the company from future dumping risk.
- Raw material pass-through structure: The business model naturally passes through vegetable oil price changes to finished product prices. Volatility, not absolute price levels, creates the earnings risk.
Nahoosh Jariwala: "Yes, perfect. Exactly it will insulate us against Chinese dumping. You have got it, you are bang on."
The Next New Product
- What is known: It uses a different raw material from the current set, stays within the core competency of vegetable oils and fatty acids, and is a higher-end product with much higher average sales value. No one makes it in India; few manufacturers exist globally.
- What is not known: Timeline, product name, exact realization premium, and margin profile. Management called it a "tricky product" taking longer than initially guessed and declined to quantify any specifics, citing competitive sensitivity.
- Development status: Work has restarted on a fast-track basis after being paused to focus on Isostearic acid. Commissioning is possibly in the last quarter of FY25, but this is a vague timeline.
Nahoosh Jariwala: "Again that product no one is making in India and we are going to make it for the first time and we want to be again one of the few manufacturers in the world. So, I hope you understand that it's not going to be an easy product."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Isostearic acid full capacity | Achieve full capacity production and sale of 2,000 metric tons annually | December 2024 |
| Isostearic acid revenue recognition | First export shipment revenue recognized after vessel reaches European port | Q4 FY24 (Jan–Mar 2024) |
| Volume growth | 12–15% volume growth for the full year | FY24 |
| 80,000-ton capacity utilization | Reach 90% utilization | Within the next year |
| Margin recovery | Return to 15%+ EBITDA margin (best level achieved during COVID) | No date; linked to Isostearic acid and new product ramp-up |
| FY25 direction | Both top-line and bottom-line growth over FY24 | FY25 |
| Grasim supply | Supply product to Grasim's plant | Plant expected on stream next quarter |
Key Metrics
| Metric | Q3 FY24 |
|---|---|
| Revenue from operations | ₹148 crores |
| Revenue from operations (9M FY24) | ₹461 crores, down ~7% YoY |
| EBITDA | ₹20 crores |
| EBITDA margin | 13.37%, up from 11.04% QoQ |
| EBITDA (9M FY24) | ₹48 crores |
| EBITDA margin (9M FY24) | 10.41% |
| Net profit after tax | approximately ₹12 crores |
| Net profit after tax (9M FY24) | down ~7% YoY |
| Quantity processed | ~15,277 metric tons |
| Quantity processed (9M FY24) | higher by ~15% YoY |
| Volume growth QoQ | ~2.64% across all products |
| Value change QoQ | decrease of ~2.8% due to lower vegetable oil prices |
| Export share of total sales | ~10% |
| Dimer acid volume | nearly 2,000 tons (Q3), nearly 6,000 tons (9M) |
| Linoleic acid volume | more than 7,000 tons (Q3), 22,000 tons (9M) |
| Isostearic acid first export shipment | ~10 tons, shipped December 2023, revenue recognition in Q4 FY24 |
| Isostearic acid annual production capacity | 2,000 metric tons at peak, expected full utilization by December 2024 |
| Current utilization of 80,000-ton capacity | more than 75% |
| FY25 utilization target for 80,000-ton capacity | 85% to 90% |
| Paint segment revenue contribution | historically ~49%–50% |
| Dimer acid revenue contribution | historically ~24%–25% |
| Isostearic acid share of world demand | hardly 5% or 6% |
| No long-term debt | for last almost 21 months |